AR and prostate neoplasm: Furthermore, CDC25B, a cell cycle phosphatase frequently overexpressed in high-grade prostate tumors, has been shown to act as a co-activator of the androgen receptor (AR), thereby promoting AR-mediated transcription even under androgen-deprived conditions [42].